LENZ logo

LENZ Therapeutics (LENZ) Company Overview

Profile

Full Name:

LENZ Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 22, 2024

Indexes:

Not included

Description:

LENZ Therapeutics focuses on developing innovative treatments for eye diseases. The company aims to improve vision and quality of life for patients through advanced therapies and research, addressing unmet medical needs in ophthalmology.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 6, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Mar 22, 2024

Analyst ratings

Recent major analysts updates

Nov 7, 24 HC Wainwright & Co.
Buy
Sep 27, 24 Raymond James
Outperform
Aug 15, 24 Piper Sandler
Overweight
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Apr 15, 24 William Blair
Outperform
Apr 15, 24 Leerink Partners
Outperform
Apr 10, 24 Citigroup
Buy
Mar 27, 24 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for LENZ Therapeutics?
  • Does LENZ Therapeutics pay dividends?
  • What sector is LENZ Therapeutics in?
  • What industry is LENZ Therapeutics in?
  • What country is LENZ Therapeutics based in?
  • When did LENZ Therapeutics go public?
  • Is LENZ Therapeutics in the S&P 500?
  • Is LENZ Therapeutics in the NASDAQ 100?
  • Is LENZ Therapeutics in the Dow Jones?
  • When was LENZ Therapeutics's last earnings report?
  • When does LENZ Therapeutics report earnings?
  • Should I buy LENZ Therapeutics stock now?

What is the ticker symbol for LENZ Therapeutics?

The ticker symbol for LENZ Therapeutics is NASDAQ:LENZ

Does LENZ Therapeutics pay dividends?

No, LENZ Therapeutics does not pay dividends

What sector is LENZ Therapeutics in?

LENZ Therapeutics is in the Healthcare sector

What industry is LENZ Therapeutics in?

LENZ Therapeutics is in the Biotechnology industry

What country is LENZ Therapeutics based in?

LENZ Therapeutics is headquartered in United States

When did LENZ Therapeutics go public?

LENZ Therapeutics's initial public offering (IPO) was on March 22, 2024

Is LENZ Therapeutics in the S&P 500?

No, LENZ Therapeutics is not included in the S&P 500 index

Is LENZ Therapeutics in the NASDAQ 100?

No, LENZ Therapeutics is not included in the NASDAQ 100 index

Is LENZ Therapeutics in the Dow Jones?

No, LENZ Therapeutics is not included in the Dow Jones index

When was LENZ Therapeutics's last earnings report?

LENZ Therapeutics's most recent earnings report was on Nov 6, 2024

When does LENZ Therapeutics report earnings?

The next expected earnings date for LENZ Therapeutics is Feb 28, 2025

Should I buy LENZ Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions